0001104659-23-085497.txt : 20230728 0001104659-23-085497.hdr.sgml : 20230728 20230728210147 ACCESSION NUMBER: 0001104659-23-085497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230726 FILED AS OF DATE: 20230728 DATE AS OF CHANGE: 20230728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cramer Pamela J. CENTRAL INDEX KEY: 0001873517 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 231124765 MAIL ADDRESS: STREET 1: C/O RHYTHM PHARMACEUTICALS STREET 2: 222 BERKELEY STREET, SUITE 1200 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 tm2322368-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-07-26 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001873517 Cramer Pamela J. 222 BERKELEY STREET, 12TH FLOOR BOSTON MA 02116 0 1 0 0 Chief Human Resources Officer 1 Common Stock 2023-07-26 4 M 0 3125 A 9348 D Common Stock 2023-07-26 4 S 0 930 17.64 D 8418 D Restricted Stock Units 2023-07-26 4 M 0 3125 0 D Common Stock 3125 6250 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Includes 81 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2023. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction dated July 24, 2021 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. The restricted stock units vest or have vested as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date. /s/ Hunter Smith, attorney-in-fact for Pamela J. Cramer 2023-07-28